Entorhinal Cortex Layer II Neurons

Entorhinal Cortex Layer II Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Entorhinal Cortex Layer II Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Entorhinal Cortex</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Entorhinal cortex layer II, lateral entorhinal area</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Stellate cells, pyramidal neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Reelin+, WFS1+, SLC30A1+, calbindin+</td>
</tr>
<tr>
<td class="label">Afferents</td>
<td>Perirhinal cortex, postrhinal cortex, lateral entorhinal area</td>
</tr>
<tr>
<td class="label">Efferents</td>
<td>Dentate gyrus (molecular layer), CA1 stratum lacunosum-moleculare</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Earliest tau pathology</td>
<td>Layer II stellate cells show NFT formation before CA1/pyramidal</td>
</tr>
<tr>
<td class="label">Reelin loss</td>
<td>Decreased Reelin+ neurons correlate with cognitive decline</td>
</tr>
<tr>
<td class="label">Grid cell disruption</td>
<td>Spatial navigation deficits precede memory impairment</td>
</tr>
<tr>
<td class="label">Perforant path degeneration</td>
<td>Loss of EC→DG projection disrupts memory encoding</td>
</tr>
<tr>
<td class="label"

Entorhinal Cortex Layer II Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Entorhinal Cortex Layer II Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Entorhinal Cortex</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Entorhinal cortex layer II, lateral entorhinal area</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Stellate cells, pyramidal neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Reelin+, WFS1+, SLC30A1+, calbindin+</td>
</tr>
<tr>
<td class="label">Afferents</td>
<td>Perirhinal cortex, postrhinal cortex, lateral entorhinal area</td>
</tr>
<tr>
<td class="label">Efferents</td>
<td>Dentate gyrus (molecular layer), CA1 stratum lacunosum-moleculare</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Earliest tau pathology</td>
<td>Layer II stellate cells show NFT formation before CA1/pyramidal</td>
</tr>
<tr>
<td class="label">Reelin loss</td>
<td>Decreased Reelin+ neurons correlate with cognitive decline</td>
</tr>
<tr>
<td class="label">Grid cell disruption</td>
<td>Spatial navigation deficits precede memory impairment</td>
</tr>
<tr>
<td class="label">Perforant path degeneration</td>
<td>Loss of EC→DG projection disrupts memory encoding</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Primary Pathology</td>
</tr>
<tr>
<td class="label">EC Layer II stellate</td>
<td>Tau NFTs</td>
</tr>
<tr>
<td class="label">Locus coeruleus neurons</td>
<td>Tau NFTs</td>
</tr>
<tr>
<td class="label">Dorsal raphe serotonin</td>
<td>Lewy bodies</td>
</tr>
<tr>
<td class="label">Substantia nigra DA</td>
<td>Lewy bodies</td>
</tr>
</table>

Introduction

Entorhinal Cortex Layer II neurons represent a critical gateway between the neocortex and hippocampus, playing essential roles in memory, spatial navigation, and episodic memory formation. These neurons are among the first to exhibit pathological changes in Alzheimer's disease, making them a focal point for understanding early neurodegeneration mechanisms[@khan2014].

EC Layer II is primarily composed of stellate cells and pyramidal neurons that project to the dentate gyrus via the perforant path. These cells express distinctive molecular markers including Reelin, WFS1 (wolframin), and SLC30A1 (zinc transporter)[@mattson2014].

Overview

Cellular Properties

Morphology

• Stellar cells: Star-shaped dendritic trees with spiny processes
• Pyramidal neurons: Triangular soma with apical dendrites
• Tangential organization: Grid-like spatial arrangement

Electrophysiology

• Regular-spiking: Prolonged depolarizing responses
• Theta rhythm: Phase-locked firing during navigation
• Grid cell properties: Hexagonal spatial firing patterns[@hafting2005]

Function

Memory Gateway

• Episodic memory formation: Binding sensory information into coherent memories
• Spatial navigation: Grid cell oscillations support path integration
• Object recognition: Integration with spatial context via lateral entorhinal area
• Semantic memory: Consolidation of factual knowledge

Grid Cell Network

Role in Neurodegeneration

Alzheimer's Disease

EC Layer II is the most vulnerable region in early AD, showing tau neurofibrillary tangles before any other cortical area (Braak Stage I)[@braak1991]:

Mechanistic cascade in AD:

Key publications:

• [Hafting et al., Grid cells in entorhinal cortex (2005)](https://doi.org/10.1038/nature04286)
• [Stranahan & Mattson, Selective vulnerability in AD (2012)](https://doi.org/10.1016/j.neurobiolaging.2010.08.005)
• [Khan et al., Reelin dysfunction in AD (2014)](https://doi.org/10.3233/JAD-132156)

Temporal Lobe Epilepsy

EC Layer II neurons are hyperactive in temporal lobe epilepsy, showing:

• Increased excitability: Downregulation of GABAergic inhibition
• Reorganization: Aberrant sprouting of mossy fibers
• Grid cell remapping: Spatial memory deficits during seizures

Frontotemporal Dementia

• Tau pathology: FTD-linked MAPT mutations cause EC Layer II degeneration
• Semantic memory loss: Disconnection between perirhinal cortex and hippocampus

Parkinson's Disease

While primarily affecting dopaminergic neurons, PD shows:

• EC involvement: Lewy body pathology in late stages
• Spatial navigation deficits: Grid cell dysfunction contributes to freezing of gait

Comparison with Other Vulnerable Neurons

Therapeutic Implications

Current Approaches

• Antiamyloid therapies: Targeting Aβ to protect EC neurons
• Tau-targeting: Preventing tau propagation from EC
• Neuroprotective agents: Supporting mitochondrial function

Emerging Strategies

• Grid cell restoration: Deep brain stimulation of EC
• Reelin supplementation: Gene therapy approaches
• Neural progenitor transplantation: Replacing lost neurons

Biomarkers

• CSF tau: Elevated p-tau181 correlates with EC degeneration
• fMRI: Reduced EC activation during spatial navigation tasks
• PET: Early tau tracers show EC uptake in preclinical AD

See Also

• [Entorhinal Cortex](/brain-regions/entorhinal-cortex)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Grid Cells
• Perforant Pathway
• [Dentate Gyrus](/brain-regions/dentate-gyrus)
• Reelin Signaling
• WFS1 Gene

The study of Entorhinal Cortex Layer Ii Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Perforant Path Presynaptic Terminal Protection Strategy](/hypothesis/h-76888762) — <span style="color:#81c784;font-weight:600">0.69</span> · Target: PPARGC1A
• [Tau-Independent Microtubule Stabilization via MAP6 Enhancement](/hypothesis/h-e12109e3) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: MAP6
• [Reelin-Mediated Cytoskeletal Stabilization Protocol](/hypothesis/h-d2df6eaf) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: RELN
• [HCN1-Mediated Resonance Frequency Stabilization Therapy](/hypothesis/h-d40d2659) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: HCN1
• [Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioenergetics](/hypothesis/h-5ff6c5ca) — <span style="color:#ffd54f;font-weight:600">0.55</span> · Target: SLC16A2
• [Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement](/hypothesis/h-57862f8a) — <span style="color:#ffd54f;font-weight:600">0.51</span> · Target: IDH2
• [Mitochondrial Calcium Buffering Enhancement via MCU Modulation](/hypothesis/h-aa8b4952) — <span style="color:#ffd54f;font-weight:600">0.49</span> · Target: MCU

Related Analyses:

• [Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) &#x1f504;